











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































43	 HD	 • Small	lesions	 • Small	lesions	 • Extra-pulmonary	
lesions	in	spleen	





• Small	lesions	 • No	abnormalities	
noted	












































































































































































































































68	 LD	 • Small	lesions	 • Small	lesions	 • No	abnormalities	
noted	
92	 LD	 • Small	lesions	 • Small	lesions	 • No	abnormalities	
noted	
93	 LD	 • Small	lesions	 • Small	lesions	 • No	abnormalities	
noted	
94	 LD	 • Small	lesions		
• 1	caseous	lesion	
• Small	lesions	 • No	abnormalities	
noted	
72	 HD	 • Small	lesions	 • Small	lesions	 • No	abnormalities	
noted	
78	 HD	 • Small	lesions	 • Small	lesions	 • No	abnormalities	
noted	
79	 HD	 • Small	lesions	 • Small	lesions	 • No	abnormalities	
noted	
88	 HD	 • Several	small	lesions	
disseminated	



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3	 • 1	small	lesion	in	lower	left	lobe	• 1	lesion	in	mediastinal	LN	
4	 • No	abnormalities	noted	 • No	abnormalities	noted	




6	 • Small	lesions	in	apical	lobe	only	• No	abnormalities	noted	








9	 • Small	lesions	in	apical	lobe	only	• No	abnormalities	noted	
10	 • Small	lesions	in	apical	lobe	only	• No	abnormalities	noted	
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Figure	3.15	Representative	H	&	E	stained	tissue	60	days	post	challenge	of	aerosol	HN878	
Mtb	in	pigs.	(A)	Healthy	lung	alveoli.	(B)	Inflammation	of	lung	parenchyma.	
	
3.	4	Conclusion	
In	this	longitudinal	study	of	neonatal	piglets,	we	characterized	T	cells,	cytokine	
profile,	and	monocytic	activation	in	response	to	BCG	stimulation	from	4	weeks	of	age	to	24	
weeks.	Our	aim	was	to	show	neonatal	piglets	can	have	similar	immunological	responses	to	
infants	vaccinated	with	BCG	whose	immunological	responses	to	in-vitro	stimulation	with	
BCG	have	been	previously	studied;	comparisons	of	the	piglets	to	infants	are	summarized	in	
Table	3.3.		
Notably,	the	predominant	T-cell	phenotypes	were	CD4+	effector	T	cells	which	
included	the	T	helper	populations	(CD3+	CD4+	and	CD3+CD4+CD8α+).	This	finding	is	in	
agreement	with	three	other	studies	measuring	T	cell	kinetics	to	BCG	in	infants	(B.	M.	
Kagina	et	al.,	2009;	Andreia	P.	Soares	et	al.,	2008;	Tena-Coki	et	al.,	2010).	These	3	studies,	
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however,	only	looked	at	one	time	point	and	were	found	to	be	in	disagreement	to	the	
longitudinal	infant	response	to	BCG	study	done	in	2013	by	Soares	et	al,	which	is	the	one	we	
aimed	to	resemble	in	setting	up	our	assays	(A.	P.	Soares	et	al.,	2013).	In	this	longitudinal	
study,	infants	were	found	to	have	a	peak	response	of	CD4+	T	cells	10	weeks	after	BCG	
vaccination	with	a	predominant	central	memory	cell	phenotype	with	characteristics	of	
effector	memory	cells	from	their	cytokine	expression(A.	P.	Soares	et	al.,	2013).	At	the	peak	
response	these	infant	CD4+	T	cells	expressed	high	levels	of	IFNγ,	TNF-α	and	IL-2	(A.	P.	
Soares	et	al.,	2013).	From	our	flow	cytometry	assay,	we	can	conclude	that	CD4+	T	cells	
were	predominantly	effector	cells	and	expressed	high	levels	of	IFN-γ	with	a	decline	4	
weeks	post	Mtb	challenge	and	a	steady	level	of	TNF-α.	The	central	memory	cells	found	in	
the	pigs	were	expressed	at	a	low	frequency,	less	than	10%,	in	comparison	to	effector	cells	
ranging	from	40-80%	in	the	four	T	cell	phenotypes.	In	the	2013	infant	study,	central	
memory	cells	are	reported	to	range	from	30-80%	as	well,	however	only	two	time	points	
were	compared	in	this	study	which	may	indicate	why	the	results	differ	from	previous	BCG	
studies	in	infants	(A.	P.	Soares	et	al.,	2013)	
A	peculiarity	observed	in	our	study	was	the	high	constitutive	expression	of	IFN-γ	
from	weeks	4-12	and	even	one	week	post	Mtb	challenge	but	a	sharp	decline	4	weeks	after	
challenge.	It	is	expected	for	IFN-γ	to	be	a	marker	of	the	magnitude	of	an	inflammatory	
response	(B.	M.	N.	Kagina	et	al.,	2010),	therefore	it	is	unusual	to	observe	high	levels	before	
the	pigs	were	challenged	with	Mtb	and	low	levels	after	challenge.	High	expression	of	IFN-γ	
was	also	observed	in	2013	longitudinal	infant	study	of	PBMCs	at	an	early	age	with	a	peak	at	
10	weeks	of	age	and	decrease	thereafter.	In	infants,	it	is	possible	to	explain	high	levels	of	
IFN-γ	due	to	continuous	exposure	to	Mtb	found	in	TB	endemic	countries.	However,	our	pigs	
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were	not	exposed	to	any	pathological	antigens	and	showed	similar	high	frequencies	to	
infants,	therefore,	there	is	reason	to	believe	this	high	expression	may	not	be	due	to	
environment	alone.	In	addition,	the	piglets	in	our	study	demonstrated	a	drastic	decline	in	
the	percentage	of	cells	expressing	IFN-γ	4	weeks	post	challenge	while	the	infants	showed	a	
decline	starting	at	10	weeks	of	age	(A.	P.	Soares	et	al.,	2013).	Further,	the	high	levels	of	IFN-
γ	should	have	induced	higher	frequencies	of	monocytes	and	upregulation	of	SLADQ	early	
on	in	the	piglets.	However,	frequency	of	monocytes	did	not	increase	until	four	weeks	post	
challenge	Figure	3.11	and	SLADQ	was	not	upregulated	until	one	week	post	challenge	
Figure	3.12.	Recent	neonatal	infant	studies	have	proposed	an	impaired	ability	of	
monocytes	to	respond	adequately	from	TLR	stimulation(Kollmann	et	al.,	2009).	Human	
infants	have	a	limited	exposure	to	antigens	in	utero	to	stimulate	adaptive	immunity	and	
therefore	rely	on	their	innate	immune	system	to	protect	against	infections	(PrabhuDas	et	
al.,	2011).	The	immaturity	of	innate	cells	present	in	infants	decreases	the	capacity	of	MHC	
class	II	antigen	presentation	and	subsequent	stimulation	of	antigen	specific	T-cell	memory	
(Dowling	&	Levy,	2014).	The	same	naïve	response	in	piglets	could	account	for	the	reason		
monocytes	in	the	piglets	studied	here	did	not	have	high	frequencies	nor	upregulated	
SLADQ	in	the	presence	of	high	IFN-γ	producing	cells	at	an	early	age		(Butler	et	al.,	2009;	M.	
Sinkora	&	Butler,	2009).		
It	is	important	to	remember	that	our	study	only	measured	expression	of	cytokines	
and	immune	cell	phenotypes	in	the	peripheral	blood.	We	speculate	the	lower	frequency	of	
IFN-γ	positive	cells	after	challenge	was	due	to	a	recruitment	of	these	cells	to	the	site	of	
infection.	Future	pig	studies	could	be	expanded	to	monitor	cytokine	expression	and	
immune	cell	phenotypes	at	the	site	of	infection	such	as	lungs	and	lymph	nodes;	this	is	an	
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added	benefit	in	using	neonatal	pigs	as	tissue	availability	in	infants	is	not	possible.	Further	
studies	to	assess	IFN-γ	response	in	PMBC	at	a	neonatal	age	could	provide	information	to	
the	role	this	cytokine	plays	at	this	time.		IFN-γ	is	the	current	indicator	used	for	vaccine	
efficacy	though	it	has	been	suggested	that	measuring	this	cytokine	alone	could	be	
misleading	due	to	the	complexity	of	memory	response,	the	short	time	periods	tested	and	
lack	of	studies	in	different	T	cell	subsets	(Henao-Tamayo	et	al.,	2010;	B.	M.	Kagina	et	al.,	
2009).		
For	expression	of	TNF-α	in	infants,	the	longitudinal	study	appeared	to	have	steady	
states	ranging	from	50-60%	in	CD4+	T	cells	from	week	6-40	with	a	decrease	at	1	year	of	
age	(A.	P.	Soares	et	al.,	2013).	IL-17	was	less	frequent	in	both	infants	and	piglets.	The	
longitudinal	infant	study	was	able	to	incorporate	IL-2	into	their	flow	cytometry	assay	and	
when	compared	to	IFNγ,	it	was	observed	to	have	the	opposite	expression	with	IFN-γ	being	
highly	expressed;	this	observation	made	the	authors	conclude	a	low	expression	of	IL-2	was	
not	typical	of	effector	cells	(A.	P.	Soares	et	al.,	2013).	Our	study	was	limited	and	therefore	
IL-2	was	measured	from	PBMC	supernatant	and	found	to	maintain	a	steady	expression	
through	most	time	points.	Without	further	knowledge	of	which	cells	were	producing	IL-2,	
we	can	only	conclude	that	general	expression	of	IL-2	stimulated	T-cell	proliferation.	
Comparing	the	upregulation	of	SLADQ	in	CD4+	T	cells,	the	2013	infant	study	only	measured	
two	time	points	and	showed	a	decrease	while	the	six	time	points	measured	in	piglets	show	
a	higher	upregulation	overall.		
There	were	three	main	benefits	to	our	study	not	possible	to	observe	in	the	
longitudinal	infant	study.	For	one,	we	were	able	to	study	CD8+,	double	positive	T	helper,	
and	double	negative	T	cells	longitudinally.	Second,	we	were	able	to	compare	vaccinated	
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animals	to	unvaccinated	control	animals.	Third,	we	were	able	to	challenge	all	pigs	with	a	
highly	virulent	clinical	strain	of	Mtb	and	determine	whether	vaccination	with	BCG	made	a	
difference	in	disease	outcome.	The	second	and	third	points	would	be	unethical	to	study	in	
infants,	nonetheless,	in	TB	endemic	countries.		
Data	for	the	BCG	CD8+	T	cell	response	exists	but	is	limited	in	infants.	Most	studies	
report	undetectable	or	low	frequency	of		IFNγ,	TNF-α	and	IL-2	cytokine	production	by	
these	cells	(B.	M.	Kagina	et	al.,	2009;	B.	M.	N.	Kagina	et	al.,	2010;	Andreia	P.	Soares	et	al.,	
2008).	However,	two	studies	report	CD8+	T	cells	with	predominant	effector	and	memory	
phenotype	supportive	of	the	results	observed	in	pigs	(Andreia	P.	Soares	et	al.,	2008;	Tena-
Coki	et	al.,	2010).	The	use	of	the	CD8α	monoclonal	antibody	was	able	to	detect	both	αβ	and	
γδ	T	cells	in	our	study,	thus	further	characterization	of	CD8+	phenotype	is	necessary.	Lee	
and	colleagues	have	already	demonstrated	the	enhanced	ability	of	γδ	T	cells	to	produce	
IFN-γ	in	BCG	vaccinated	pigs	(Lee	et	al.,	2004).	Generally,	αβ	T	cells	are	considered	the	
most	important	T	cell	subtype	in	response	to	TB,	however,	with	Lee’s	results	and	our	
observations	of	double	negative	T	cells	which	contain	γδ	T	cells	it	is	clear	this	phenotype	
plays	an	important	role	in	mediating	an	immune	response	(Lee	et	al.,	2004).	
From	an	extensive	search,	no	studies	appear	on	double	negative	T	cells	or	double	
positive	T	helper	cells	in	infant	response	to	BCG.	Inclusion	of	the	CD8α	monoclonal	
antibody	along	with	CD4	in	our	flow	cytometry	panels	allowed	the	study	of	the	double	
positive	T	helper	cell	population	not	included	in	any	of	the	BCG	infant	studies	referenced	
here.	Our	study	suggests	this	population	may	have	a	role	in	establishment	of	central	
memory	T	cells	with	BCG	antigen	early	on	after	vaccination	and	the	T	helper	cell	population	
with	the	highest	upregulation	4	weeks	post	challenge,	Figure	3.7.	In	addition,	these	were	
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the	most	prominent	T	cells	demonstrating	an	effector	phenotype,	Figure	3.8.	It	is	generally	
believed	that	co-expression	of	CD4	and	CD8	only	occurs	transiently	in	the	thymus	before	
negative	selection	in	which	T	cells	are	committed	to	single	expression	of	CD4	or	CD8	(Koch	
&	Radtke,	2011).	However,	both	pigs	and	NHPs	have	shown	large	populations	of	these	
double	positive	T	cells	in	peripheral	lymphoid	tissues	and	blood.	This	population	of	T	cells	
was	first	described	in	humans	in	1986(Blue,	Daley,	Levine,	Craig,	&	Schlossman,	1986).	
Double	positive	T	cells		have	the	capability	of	expressing	memory	markers	and	maintain	co-
expression	of	CD4	and	CD8	for	one	year	in	culture	(Overgaard,	Jung,	Steptoe,	&	Wells,	
2015).	Further,	these	cells	are	proven	to	be	thymically	derived	as	they	express		CD8ab	
(Overgaard	et	al.,	2015).	They	have	been	found	to	increase	with	age	in	both	humans	and	
NHPs	yet	their	function	and	development	is	largely	unknown	and	conflicting	studies	exist	
(Overgaard	et	al.,	2015).	In	pigs,	these	double	positive	cells	have	also	been	described	and	
defined	as	T	helper	cells(Gerner	et	al.,	2015;	Saalmuller,	Reddehase,	Buhring,	Jonjic,	&	
Koszinowski,	1987).	Further,	ontogenic	studies	have	shown	this	T	cell	population	
continuously	expands	in	the	blood	from	birth	to	adulthood	and	proliferate	with	antigenic	
stimulation	(Gerner	et	al.,	2015).		
These	different	T	cell	populations	may	be	important	in	determining	whether	
frequencies	of	specific	cells,	patterns	of	cytokine	expression	and	memory	phenotype	may	
be	important	for	long-term	protection	against	TB	(B.	M.	N.	Kagina	et	al.,	2010).	The	few	
statistical	differences	found	between	the	BCG	vaccinated	and	unvaccinated	pigs	support	
the	theory	that	BCG	does	not	confer	reliable	protection	against	Mtb	and	additional	factors	
play	a	role	in	its	variable	efficacy.	Furthermore,	the	two	pig	groups	were	more	similar	than	
different	and	could	be	used	in	the	future	to	study	general	neonatal	immunology	not	just	to	
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BCG	response.	These	similarities	were	observed	again	after	Mtb	challenge,	in	which	TB-
compatible	lesions	were	found	to	be	homogeneous	through	all	10	pigs,	none	of	the	animals	
produced	viable	bacilli	or	demonstrated	clinical	TB	symptoms.	A	difference	may	have	been	
observed	if	the	animals	were	kept	with	the	infection	for	a	longer	period	of	time	such	as	for	
9	months	as	the	adult	pigs	were.		
Overall,	our	results	support	previous	infant	BCG	studies	with	the	observation	of	
CD4+	and	CD8+	effector	T	cells.	Additionally,	it	provides	the	study	of	populations,	which	
may	play	a	role	in	the	BCG	response	and	currently	ignored.	Importantly,	it	demonstrates	
pigs	are	capable	of	producing	similar	immune	cell	phenotypes	to	infants	and	thus	should	be	
considered	as	an	important	animal	model	in	future	TB	vaccine	studies.	
Table	3.3	Comparison	of	results	from	previous	studies	in	infants	vaccinated	with	BCG	and	
mini-pig	results	
T	cell	phenotypes	
and	cytokine	profiles	
in	response	to	BCG	
in-vitro	stimulation	
Mini-pigs	 Infants	 Reference	
Predominant	CD4+	T	
cell	memory	
phenotype	
effector	T	cells	 effector	T	cells	 (B.	M.	Kagina	et	
al.,	2009;	Andreia	
P.	Soares	et	al.,	
2008;	Tena-Coki	
et	al.,	2010)	
Predominant	
cytokines	expressed	
by	CD4+	T	cells	
IFNγ,	TNF-α	 IFNγ,	TNF-α	 (A.	P.	Soares	et	al.,	
2013)	
Frequency	of	central	
memory	cells	
10%	 30-80%	 (A.	P.	Soares	et	al.,	
2013)	
Upregulation	of	
SLADQ	in	CD4+	T	cells	
Increased	over	6	
time	points	
measured	
Decreased	over	2	
time	points	
measured	
(A.	P.	Soares	et	al.,	
2013)	
Predominant	CD8+	T	
cell	memory	
phenotype	
Memory	and	
effector	T	cells	
Memory	and	effector	
T	cells	
Andreia	P.	Soares	
et	al.,	2008;	Tena-
Coki	et	al.,	2010)	
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Chapter	4:	Concluding	Remarks	
	
	
	
The	overall	goal	of	this	project	was	to	demonstrate	the	capabilities	of	pigs	as	a	
model	for	TB	vaccine	development	with	a	focus	on	neonatal	immunology.	In	order	to	
demonstrate	its	potential	for	vaccine	development	we	first	established	Mtb	infection	in	
adult	pigs	and	later	in	two	groups	of	younger	pigs.	As	reported,	in	the	adult	pigs	TB-
compatible	lesions	were	abundant	and	of	heterogeneous	nature	similar	to	human	TB	
lesions.	The	two	month	old	pigs	and	the	pigs	used	to	monitor	T	cell	and	monocyte	kinetics	
in	response	to	BCG	demonstrated	fewer	TB-compatible	lesions	with	more	homogeneity	but	
were	also	only	monitored	for	two	months	post	challenge	as	opposed	to	nine	months	in	the	
adults.	In	all	three	groups	of	pigs,	none	of	the	animals	showed	clinical	symptoms	indicating	
active	TB	except	for	the	one	time	reported	in	chapter	2.	However,	the	TB-compatible	
lesions	seen	in	the	unchallenged	animals	as	well	as	some	culturable	CFUs	suggest	
transmission	from	the	challenged	animals.	These	results	support	the	continuous	use	of	pigs	
for	future	studies	in	the	TB	field.	Since	these	animals	did	not	demonstrate	any	symptoms	
yet	showed	transmission	of	Mtb	bacilli	they	can	be	further	studied	as	a	model	for	TB	
disease	in	children.	Further,	new	diagnostic	techniques	for	children	could	be	studied	in	
pigs,	since	children	do	not	typically	show	prominent	TB	symptoms	as	adults	do	thus	
making	it	difficult	to	diagnose	them	with	the	current	available	techniques.	In	addition,	
establishing	Mtb	infection	with	a	highly	virulent	clinical	strain	in	pigs	was	an	important	
accomplishment	as	later	vaccine	efficacy	or	new	therapeutics	could	be	tested	against	a	
similar	Mtb	challenge.		
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More	importantly,	a	gap	in	the	knowledge	of	the	immunological	kinetics	induced	by	
BCG	continues	to	exist	almost	100	years	since	the	first	doses	of	BCG	were	administered.	
Pigs	have	a	full	range	of	innate	and	adaptive	immune	effectors	and	with	the	wide	
availability	of	pig	specific	reagents	along	with	more	than	an	80%	similarity	in	immunity	to	
humans	makes	for	a	model	with	great	potential	to	study	the	immunological	response	
induced	by	BCG	(Meurens	et	al.,	2012).	Similar	to	infants,	piglets	are	immunocompetent	at	
birth	but	immunologically	immature	(Meurens	et	al.,	2012).	By	use	of	flow	cytometry,	we	
were	able	to	characterize	the	neonatal	immune	response	induced	by	BCG	longitudinally	in	
piglets	and	compare	it	to	recent	studies	in	infants	living	in	TB	endemic	countries.	Our	
findings	were	similar	to	BCG	vaccinated	infant	studies	with	a	predominance	of	effector	
cells,	supporting	the	use	of	neonatal	piglets	for	further	use	in	TB	vaccine	development.	In	
addition,	we	were	able	to	monitor	unvaccinated	pigs	and	compare	them	to	BCG	vaccinated	
pigs.	Although,	few	significant	differences	between	the	groups	existed,	this	could	be	further	
studied	to	determine	the	lack	of	efficacy	BCG	has	on	pulmonary	TB	as	well	as	lack	of	
protection	from	the	recent	phase	IIb	MVA85A	clinical	trial	or	the	neonatal	immune	
response	overall.		
It	is	important	to	highlight	the	benefits	of	neonatal	piglets	for	potential	TB	studies	in	
the	future.	Lee	and	colleagues	have	already	confirmed	pigs	are	an	appropriate	animal	
model	to	study	cell-mediated	immune	responses	to	BCG	setting	up	a	platform	for	our	more	
in-depth	longitudinal	study	(Lee	et	al.,	2004).	In	order	to	better	understand	the	neonatal	
adaptive	immune	response,	it	is	valuable	to	separate	environmental	factors	from	intrinsic	
(Butler	et	al.,	2009).	The	piglet	has	better	potential	in	separating	these	concerns	in	
comparison	to	rodents	or	NHPs	as	neither	the	environmental	nor	maternal	factors,	such	as	
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transmission	of	maternal	immunoregulators	in	utero	or	rearing	after	birth	without	their	
mothers,	can	be	controlled	in	these	animals	(Butler	et	al.,	2009).	Pigs	develop	precosial	
offspring	and	only	acquire	protective	antibodies	from	colostrum,	thus	can	be	reared	after	
birth	in	various	ways	depending	on	a	study’s	interest	(Butler	et	al.,	2009).	In	germ-free	
(GF)	isolators,	studies	can	control	the	piglets	exposure	to	food,	commensal	organisms,	
pathogens,	maternal	antibodies	and	other	maternal	regulatory	factors	(M.	Sinkora	&	Butler,	
2016).	In	addition,	the	114	day	gestation	period	of	pigs	provides	ample	time	to	study	the	
lymphoid	system	development	of	fetal	pigs	without	interference	from	passive	maternal	
antibodies	and	other	maternal	regulatory	factors	(M.	Sinkora	&	Butler,	2016).	For	the	
purpose	of	our	study,	we	did	not	investigate	fetal	development	and	allowed	the	neonatal	
piglets	to	nurse	from	their	mothers’	until	3-4	weeks	of	age.	For	improved	establishment	of	
pigs	as	an	animal	model	in	TB	it	would	be	important	to	find	an	optimal	dose	of	Mtb	causing	
more	prominent	active	TB	symptoms.	It	would	also	be	beneficial	to	study	the	
immunological	response	sooner	than	4	weeks	of	age	as	done	here.	The	current	regimen	of	
BCG	vaccine	administration	is	done	48	hours	after	birth	in	most	countries,	studies	have	
suggested	delaying	vaccination	after	10	weeks	of	age	would	be	more	optimal	(B.	M.	Kagina	
et	al.,	2009;	A.	P.	Soares	et	al.,	2013),	however	little	to	no	data	exists	on	the	immunological	
state	in	newborns	48	hours	after	birth;	neonatal	pigs	could	provide	insight	into	this	early	
response	without	the	ethical	concern	of	studying	infants	at	such	a	young	age.	Since	taking	
extensive	samples	from	human	subjects	is	logistically	and	ethically	challenging,	the	pig	
offers	comparative	similarities	with	infants	and	can	be	used	as	subjects	allowing	extensive	
sampling	for	long	periods	of	time	(Lee	et	al.,	2004).	The	current	use	of	murine	models	do	
not	translate	directly	to	humans	and	thus	mandate	use	of	intermediate	animals	before	
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human	clinical	trials;	pigs	have	been	proven	to	be	useful	in	modeling	the	human	immune	
system	and	thus	have	the	potential	to	skip	intermediate	animal	models	(Boeker,	Pabst,	&	
Rothkotter,	1999).	Overall,	with	the	establishment	of	Mtb	infection,	wide	availability	of	pig	
specific	reagents,	ease	of	animal	handling	and	capability	of	study	manipulation,	the	piglet	is	
an	important	model	for	TB	and	needs	to	be	incorporated	in	future	vaccine	efficacy	studies,	
diagnostics	and	improved	therapeutics.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 109	
References	
	
	
	
Aigner,	B.,	Renner,	S.,	Kessler,	B.,	Klymiuk,	N.,	Kurome,	M.,	Wunsch,	A.,	&	Wolf,	E.	(2010).	
Transgenic	pigs	as	models	for	translational	biomedical	research.	J	Mol	Med	(Berl),	
88(7),	653-664.	doi:10.1007/s00109-010-0610-9	
Alliance,	T.	(2016).	Inadequate	Treatment.			Retrieved	from	
http://www.tballiance.org/why-new-tb-drugs/inadequate-treatment	
Armstrong,	J.	A.,	&	Hart,	P.	D.	(1971).	Response	of	cultured	macrophages	to	Mycobacterium	
tuberculosis,	with	observations	on	fusion	of	lysosomes	with	phagosomes.	J	Exp	Med,	
134(3	Pt	1),	713-740.		
Arnold,	C.	(2013).	Tuberculosis	vaccine	faces	setbacks	but	optimism	remains.	Lancet	Respir	
Med,	1(1),	13.	doi:10.1016/s2213-2600(13)70030-4	
Bambery,	R.	K.	(2016).	International	Swine	Genome	Sequencing	Consortium.			Retrieved	
from	http://piggenome.org/	
Blue,	M.	L.,	Daley,	J.	F.,	Levine,	H.,	Craig,	K.	A.,	&	Schlossman,	S.	F.	(1986).	Biosynthesis	and	
surface	expression	of	T8	by	peripheral	blood	T4+	cells	in	vitro.	J	Immunol,	137(4),	
1202-1207.		
Boeker,	M.,	Pabst,	R.,	&	Rothkotter,	H.	J.	(1999).	Quantification	of	B,	T	and	null	lymphocyte	
subpopulations	in	the	blood	and	lymphoid	organs	of	the	pig.	Immunobiology,	201(1),	
74-87.	doi:10.1016/s0171-2985(99)80048-5	
Bullido,	R.,	Domenech,	N.,	Alvarez,	B.,	Alonso,	F.,	Babin,	M.,	Ezquerra,	A.,	.	.	.	Dominguez,	J.	
(1997).	Characterization	of	five	monoclonal	antibodies	specific	for	swine	class	II	
major	histocompatibility	antigens	and	crossreactivity	studies	with	leukocytes	of	
domestic	animals.	Dev	Comp	Immunol,	21(3),	311-322.		
Bullido,	R.,	Gomez	del	Moral,	M.,	Domenech,	N.,	Alonso,	F.,	Ezquerra,	A.,	&	Dominguez,	J.	
(1997).	Monoclonal	antibodies	to	a	high	molecular	weight	isoform	of	porcine	CD45:	
biochemical	and	tissue	distribution	analyses.	Vet	Immunol	Immunopathol,	56(1-2),	
151-162.		
Butler,	J.	E.,	Lager,	K.	M.,	Splichal,	I.,	Francis,	D.,	Kacskovics,	I.,	Sinkora,	M.,	.	.	.	Ramsoondar,	J.	
(2009).	The	piglet	as	a	model	for	B	cell	and	immune	system	development.	Vet	
Immunol	Immunopathol,	128(1-3),	147-170.	doi:10.1016/j.vetimm.2008.10.321	
Campbell,	J.	J.,	Murphy,	K.	E.,	Kunkel,	E.	J.,	Brightling,	C.	E.,	Soler,	D.,	Shen,	Z.,	.	.	.	Wu,	L.	
(2001).	CCR7	expression	and	memory	T	cell	diversity	in	humans.	J	Immunol,	166(2),	
877-884.		
Cepeda,	M.,	Salas,	M.,	Folwarczny,	J.,	Leandro,	A.	C.,	Hodara,	V.	L.,	de	la	Garza,	M.	A.,	.	.	.	
Gauduin,	M.	C.	(2013).	Establishment	of	a	neonatal	rhesus	macaque	model	to	study	
Mycobacterium	tuberculosis	infection.	Tuberculosis	(Edinb),	93	Suppl,	S51-59.	
doi:10.1016/s1472-9792(13)70011-8	
Clark,	S.,	Hall,	Y.,	&	Williams,	A.	(2015).	Animal	models	of	tuberculosis:	Guinea	pigs.	Cold	
Spring	Harb	Perspect	Med,	5(5),	a018572.	doi:10.1101/cshperspect.a018572	
Cooper,	A.	M.	(2009).	Cell	mediated	immune	responses	in	Tuberculosis.	Annu	Rev	Immunol,	
27,	393-422.	doi:10.1146/annurev.immunol.021908.132703	
Cooper,	A.	M.	(2015).	Mouse	model	of	tuberculosis.	Cold	Spring	Harb	Perspect	Med,	5(2),	
a018556.	doi:10.1101/cshperspect.a018556	
	 110	
Cruz-Knight,	W.,	&	Blake-Gumbs,	L.	(2013).	Tuberculosis:	an	overview.	Prim	Care,	40(3),	
743-756.	doi:10.1016/j.pop.2013.06.003	
Dawson,	H.	D.,	Loveland,	J.	E.,	Pascal,	G.,	Gilbert,	J.	G.,	Uenishi,	H.,	Mann,	K.	M.,	.	.	.	Tuggle,	C.	K.	
(2013).	Structural	and	functional	annotation	of	the	porcine	immunome.	BMC	
Genomics,	14,	332.	doi:10.1186/1471-2164-14-332	
Desikan,	P.	(2013).	Sputum	smear	microscopy	in	tuberculosis:	is	it	still	relevant?	Indian	J	
Med	Res,	137(3),	442-444.		
Donovan,	J.	A.,	&	Koretzky,	G.	A.	(1993).	CD45	and	the	immune	response.	J	Am	Soc	Nephrol,	
4(4),	976-985.		
Dowling,	D.	J.,	&	Levy,	O.	(2014).	Ontogeny	of	early	life	immunity.	Trends	Immunol,	35(7),	
299-310.	doi:10.1016/j.it.2014.04.007	
Driver,	E.	R.,	Ryan,	G.	J.,	Hoff,	D.	R.,	Irwin,	S.	M.,	Basaraba,	R.	J.,	Kramnik,	I.,	&	Lenaerts,	A.	J.	
(2012).	Evaluation	of	a	mouse	model	of	necrotic	granuloma	formation	using	
C3HeB/FeJ	mice	for	testing	of	drugs	against	Mycobacterium	tuberculosis.	
Antimicrob	Agents	Chemother,	56(6),	3181-3195.	doi:10.1128/aac.00217-12	
Ehlers,	S.,	&	Schaible,	U.	E.	(2012).	The	granuloma	in	tuberculosis:	dynamics	of	a	host-
pathogen	collusion.	Front	Immunol,	3,	411.	doi:10.3389/fimmu.2012.00411	
Ellis,	R.	D.,	Hatherill,	M.,	Tait,	D.,	Snowden,	M.,	Churchyard,	G.,	Hanekom,	W.,	.	.	.	Ginsberg,	A.	
M.	(2015).	Innovative	clinical	trial	designs	to	rationalize	TB	vaccine	development.	
Tuberculosis	(Edinb),	95(3),	352-357.	doi:10.1016/j.tube.2015.02.036	
Fennelly,	K.	P.,	Jones-López,	E.	C.,	Ayakaka,	I.,	Kim,	S.,	Menyha,	H.,	Kirenga,	B.,	.	.	.	Ellner,	J.	J.	
(2012).	Variability	of	Infectious	Aerosols	Produced	during	Coughing	by	Patients	
with	Pulmonary	Tuberculosis.	http://dx.doi.org/10.1164/rccm.201203-0444OC.	
doi:10.1164/rccm.201203-0444OC	
Flynn,	J.	L.,	&	Chan,	J.	(2001).	Immunology	of	tuberculosis.	Annu	Rev	Immunol,	19,	93-129.	
doi:10.1146/annurev.immunol.19.1.93	
Fogel,	N.	(2015).	Tuberculosis:	a	disease	without	boundaries.	Tuberculosis	(Edinb),	95(5),	
527-531.	doi:10.1016/j.tube.2015.05.017	
Ganguly,	N.,	Siddiqui,	I.,	&	Sharma,	P.	(2008).	Role	of	M.	tuberculosis	RD-1	region	encoded	
secretory	proteins	in	protective	response	and	virulence.	Tuberculosis	(Edinb),	88(6),	
510-517.	doi:10.1016/j.tube.2008.05.002	
Gerner,	W.,	Talker,	S.	C.,	Koinig,	H.	C.,	Sedlak,	C.,	Mair,	K.	H.,	&	Saalmuller,	A.	(2015).	
Phenotypic	and	functional	differentiation	of	porcine	alphabeta	T	cells:	current	
knowledge	and	available	tools.	Mol	Immunol,	66(1),	3-13.	
doi:10.1016/j.molimm.2014.10.025	
Getahun,	H.,	Matteelli,	A.,	Chaisson,	R.	E.,	&	Raviglione,	M.	(2015).	Latent	Mycobacterium	
tuberculosis	infection.	N	Engl	J	Med,	372(22),	2127-2135.	
doi:10.1056/NEJMra1405427	
Gil,	O.,	Diaz,	I.,	Vilaplana,	C.,	Tapia,	G.,	Diaz,	J.,	Fort,	M.,	.	.	.	Cardona,	P.	J.	(2010).	Granuloma	
encapsulation	is	a	key	factor	for	containing	tuberculosis	infection	in	mini-pigs.	PLoS	
One,	5(4),	e10030.	doi:10.1371/journal.pone.0010030	
Goenka,	A.,	&	Kollmann,	T.	R.	(2015).	Development	of	immunity	in	early	life.	J	Infect,	71	
Suppl	1,	S112-120.	doi:10.1016/j.jinf.2015.04.027	
Gonzalez-Juarrero,	M.,	Bosco-Lauth,	A.,	Podell,	B.,	Soffler,	C.,	Brooks,	E.,	Izzo,	A.,	.	.	.	Bowen,	
R.	(2013).	Experimental	aerosol	Mycobacterium	bovis	model	of	infection	in	goats.	
Tuberculosis	(Edinb),	93(5),	558-564.	doi:10.1016/j.tube.2013.05.006	
	 111	
Gupta,	U.	D.,	&	Katoch,	V.	M.	(2005).	Animal	models	of	tuberculosis.	Tuberculosis	(Edinb),	
85(5-6),	277-293.	doi:10.1016/j.tube.2005.08.008	
Hawn,	T.	R.,	Day,	T.	A.,	Scriba,	T.	J.,	Hatherill,	M.,	Hanekom,	W.	A.,	Evans,	T.	G.,	.	.	.	Self,	S.	G.	
(2014).	Tuberculosis	Vaccines	and	Prevention	of	Infection.	Microbiol	Mol	Biol	Rev,	
78(4),	650-671.	doi:10.1128/mmbr.00021-14	
Helb,	D.,	Jones,	M.,	Story,	E.,	Boehme,	C.,	Wallace,	E.,	Ho,	K.,	.	.	.	Alland,	D.	(2010).	Rapid	
Detection	of	Mycobacterium	tuberculosis	and	Rifampin	Resistance	by	Use	of	On-
Demand,	Near-Patient	Technology▿��	‡.	J	Clin	Microbiol,	48(1),	229-237.	
doi:10.1128/jcm.01463-09	
Henao-Tamayo,	M.	I.,	Ordway,	D.	J.,	Irwin,	S.	M.,	Shang,	S.,	Shanley,	C.,	&	Orme,	I.	M.	(2010).	
Phenotypic	definition	of	effector	and	memory	T-lymphocyte	subsets	in	mice	
chronically	infected	with	Mycobacterium	tuberculosis.	Clin	Vaccine	Immunol,	17(4),	
618-625.	doi:10.1128/cvi.00368-09	
Hlavova,	K.,	Stepanova,	H.,	&	Faldyna,	M.	(2014).	The	phenotype	and	activation	status	of	T	
and	NK	cells	in	porcine	colostrum	suggest	these	are	central/effector	memory	cells.	
Vet	J,	202(3),	477-482.	doi:10.1016/j.tvjl.2014.09.008	
Hodgins,	D.	C.,	&	Shewen,	P.	E.	(2012).	Vaccination	of	neonates:	problem	and	issues.	
Vaccine,	30(9),	1541-1559.	doi:10.1016/j.vaccine.2011.12.047	
Holderness,	J.,	Hedges,	J.	F.,	Ramstead,	A.,	&	Jutila,	M.	A.	(2013).	Comparative	Biology	of	γδ	T	
Cell	Function	in	Humans,	Mice,	and	Domestic	Animals.	
http://dx.doi.org/10.1146/annurev-animal-031412-103639.	doi:10.1146/annurev-
animal-031412-103639	
Holt,	P.	G.,	&	Jones,	C.	A.	(2000).	The	development	of	the	immune	system	during	pregnancy	
and	early	life.	Allergy,	55(8),	688-697.		
Horsburgh,	C.	R.,	Jr.,	Barry,	C.	E.,	3rd,	&	Lange,	C.	(2015).	Treatment	of	Tuberculosis.	N	Engl	J	
Med,	373(22),	2149-2160.	doi:10.1056/NEJMra1413919	
Horter,	D.	C.,	Yoon,	K.	J.,	&	Zimmerman,	J.	J.	(2003).	A	review	of	porcine	tonsils	in	immunity	
and	disease.	Anim	Health	Res	Rev,	4(2),	143-155.		
Houben,	D.,	Demangel,	C.,	van	Ingen,	J.,	Perez,	J.,	Baldeon,	L.,	Abdallah,	A.	M.,	.	.	.	Peters,	P.	J.	
(2012).	ESX-1-mediated	translocation	to	the	cytosol	controls	virulence	of	
mycobacteria.	Cell	Microbiol,	14(8),	1287-1298.	doi:10.1111/j.1462-
5822.2012.01799.x	
Hunter,	R.	L.	(2011).	Pathology	of	post	primary	tuberculosis	of	the	lung:	an	illustrated	
critical	review.	Tuberculosis	(Edinb),	91(6),	497-509.	
doi:10.1016/j.tube.2011.03.007	
Ibrahim,	Z.,	Busch,	J.,	Awwad,	M.,	Wagner,	R.,	Wells,	K.,	&	Cooper,	D.	K.	(2006).	Selected	
physiologic	compatibilities	and	incompatibilities	between	human	and	porcine	organ	
systems.	Xenotransplantation,	13(6),	488-499.	doi:10.1111/j.1399-
3089.2006.00346.x	
Initiative,	G.	L.	(2013).	The	Handbook	-	Laboratory	Diagnosis	of	Tuberculosis	by	Sputum	
Microscopy	-	tb-sputum-microscopy-handbook.pdf:	SA	Pathology.	
Institute,	B.	(2016).	Guinea	Pig	Genome	Project	|	Broad	Institute	of	MIT	and	Harvard.			
Retrieved	from	https://www.broadinstitute.org/scientific-
community/science/projects/mammals-models/guinea-pig/guinea-pig-genome-
project	
	 112	
Kagina,	B.	M.,	Abel,	B.,	Bowmaker,	M.,	Scriba,	T.	J.,	Gelderbloem,	S.,	Smit,	E.,	.	.	.	Hanekom,	W.	
A.	(2009).	Delaying	BCG	vaccination	from	birth	to	10	weeks	of	age	may	result	in	an	
enhanced	memory	CD4	T	cell	response.	Vaccine,	27(40),	5488-5495.	
doi:10.1016/j.vaccine.2009.06.103	
Kagina,	B.	M.	N.,	Abel,	B.,	Scriba,	T.	J.,	Hughes,	E.	J.,	Keyser,	A.,	Soares,	A.,	.	.	.	Hanekom,	W.	A.	
(2010).	Specific	T	Cell	Frequency	and	Cytokine	Expression	Profile	Do	Not	Correlate	
with	Protection	against	Tuberculosis	after	Bacillus	Calmette-Guérin	Vaccination	of	
Newborns.	Am	J	Respir	Crit	Care	Med,	182(8),	1073-1079.	
doi:10.1164/rccm.201003-0334OC	
Kaushal,	D.,	Division	of	Bacteriology	&	Parasitology,	T.	N.	P.	R.	C.,	Covington,	LA,	USA,	
Department	of	Microbiology	&	Immunology,	T.	U.	S.	o.	M.,	New	Orleans,	LA,	USA,	
Mehra,	S.,	Division	of	Bacteriology	&	Parasitology,	T.	N.	P.	R.	C.,	Covington,	LA,	USA,	
Didier,	P.	J.,	.	.	.	Division	of	Comparative	Pathology,	T.	N.	P.	R.	C.,	Covington,	LA,	USA.	
(2012).	The	non‐human	primate	model	of	tuberculosis.	Journal	of	Medical	
Primatology,	41(3),	191-201.	doi:10.1111/j.1600-0684.2012.00536.x	
Koch,	U.,	&	Radtke,	F.	(2011).	Mechanisms	of	T	cell	development	and	transformation.	Annu	
Rev	Cell	Dev	Biol,	27,	539-562.	doi:10.1146/annurev-cellbio-092910-154008	
Kollmann,	T.	R.,	Crabtree,	J.,	Rein-Weston,	A.,	Blimkie,	D.,	Thommai,	F.,	Wang,	X.	Y.,	.	.	.	
Wilson,	C.	B.	(2009).	Neonatal	innate	TLR-mediated	responses	are	distinct	from	
those	of	adults.	J	Immunol,	183(11),	7150-7160.	doi:10.4049/jimmunol.0901481	
Korf,	J.,	Department	of	Molecular	Biomedical	Research,	M.	I.	U.,	VIB,	Ghent	University,	
Ghent,	Belgium,	Department	of	Ultrastructure,	I.	a.	P.,	Unit	of	Cellular	Immunology,	
VIB,	Free	University	of	Brussels,	Brussels,	Belgium,	Stoltz,	A.,	Department	of	
Biochemistry,	U.	o.	P.,	Pretoria,	South	Africa,	Verschoor,	J.,	.	.	.	Department	for	
Molecular	Biomedical	Research,	V.	G.	U.,	Technologiepark 927,	9052	Ghent	
(Zwijnaarde),	Belgium,	Fax:	+32‐9‐3313‐609.	(2005).	The	Mycobacterium	
tuberculosis	cell	wall	component	mycolic	acid	elicits	pathogen‐associated	host	
innate	immune	responses.	European	Journal	of	Immunology,	35(3),	890-900.	
doi:10.1002/eji.200425332	
Lee,	J.,	Choi,	K.,	Olin,	M.	R.,	Cho,	S.	N.,	&	Molitor,	T.	W.	(2004).	Gammadelta	T	cells	in	
immunity	induced	by	Mycobacterium	bovis	bacillus	Calmette-Guerin	vaccination.	
Infect	Immun,	72(3),	1504-1511.		
Lerm,	M.,	Sweden,	F.	o.	M.	a.	H.	S.	D.	o.	M.	a.	M.	M.	L.,	Netea,	M.	G.,	&	Netherlands,	R.	U.	M.	C.	
R.	I.	f.	M.	L.	S.	D.	o.	I.	M.	N.	t.	(2016).	Trained	immunity:	a	new	avenue	for	tuberculosis	
vaccine	development.	Journal	of	Internal	Medicine.	doi:10.1111/joim.12449	
Luca,	S.,	&	Mihaescu,	T.	(2013).	History	of	BCG	Vaccine.	Maedica	(Buchar),	8(1),	53-58.		
Lunney,	J.	K.,	&	Pescovitz,	M.	D.	(1987).	Phenotypic	and	functional	characterization	of	pig	
lymphocyte	populations.	Vet	Immunol	Immunopathol,	17(1-4),	135-144.		
Manca,	C.,	Tsenova,	L.,	Bergtold,	A.,	Freeman,	S.,	Tovey,	M.,	Musser,	J.	M.,	.	.	.	Kaplan,	G.	
(2001).	Virulence	of	a	Mycobacterium	tuberculosis	clinical	isolate	in	mice	is	
determined	by	failure	to	induce	Th1	type	immunity	and	is	associated	with	induction	
of	IFN-alpha	/beta.	Proc	Natl	Acad	Sci	U	S	A,	98(10),	5752-5757.	
doi:10.1073/pnas.091096998	
	 113	
Marais,	B.	J.,	Gie,	R.	P.,	Schaaf,	H.	S.,	Beyers,	N.,	Donald,	P.	R.,	&	Starke,	J.	R.	(2006).	Childhood	
pulmonary	tuberculosis:	old	wisdom	and	new	challenges.	Am	J	Respir	Crit	Care	Med,	
173(10),	1078-1090.	doi:10.1164/rccm.200511-1809SO	
Marchant,	A.,	&	Goldman,	M.	(2005).	T	cell-mediated	immune	responses	in	human	
newborns:	ready	to	learn?	Clin	Exp	Immunol,	141(1),	10-18.	doi:10.1111/j.1365-
2249.2005.02799.x	
McCullough,	K.	C.,	Schaffner,	R.,	Natale,	V.,	Kim,	Y.	B.,	&	Summerfield,	A.	(1997).	Phenotype	
of	porcine	monocytic	cells:	modulation	of	surface	molecule	expression	upon	
monocyte	differentiation	into	macrophages.	Vet	Immunol	Immunopathol,	58(3-4),	
265-275.		
McShane,	H.,	Pathan,	A.	A.,	Sander,	C.	R.,	Keating,	S.	M.,	Gilbert,	S.	C.,	Huygen,	K.,	.	.	.	Hill,	A.	V.	
(2004).	Recombinant	modified	vaccinia	virus	Ankara	expressing	antigen	85A	boosts	
BCG-primed	and	naturally	acquired	antimycobacterial	immunity	in	humans.	Nat	
Med,	10(11),	1240-1244.	doi:10.1038/nm1128	
McShane,	H.,	&	Williams,	A.	(2014).	A	review	of	preclinical	animal	models	utilised	for	TB	
vaccine	evaluation	in	the	context	of	recent	human	efficacy	data.	Tuberculosis	
(Edinb),	94(2),	105-110.	doi:10.1016/j.tube.2013.11.003	
Meurens,	F.,	Summerfield,	A.,	Nauwynck,	H.,	Saif,	L.,	&	Gerdts,	V.	(2012).	The	pig:	a	model	
for	human	infectious	diseases.	Trends	Microbiol,	20(1),	50-57.	
doi:10.1016/j.tim.2011.11.002	
Moliva,	J.	I.,	Turner,	J.,	&	Torrelles,	J.	B.	(2015).	Prospects	in	Mycobacterium	bovis	Bacille	
Calmette	et	Guérin	(BCG)	vaccine	diversity	and	delivery:	Why	does	BCG	fail	to	
protect	against	tuberculosis?	Elsevier,	33(39),	5035–5041.	
doi:10.1016/j.vaccine.2015.08.033	
Moreno,	S.,	Alvarez,	B.,	Martinez,	P.,	Uenishi,	H.,	Revilla,	C.,	Ezquerra,	A.,	.	.	.	Dominguez,	J.	
(2013).	Analysis	of	chemokine	receptor	CCR7	expression	on	porcine	blood	T	
lymphocytes	using	a	CCL19-Fc	fusion	protein.	Dev	Comp	Immunol,	39(3),	207-213.	
doi:10.1016/j.dci.2012.11.010	
Moyo,	S.,	Verver,	S.,	Mahomed,	H.,	Hawkridge,	A.,	Kibel,	M.,	Hatherill,	M.,	.	.	.	Hussey,	G.	
(2010).	Age-related	tuberculosis	incidence	and	severity	in	children	under	5	years	of	
age	in	Cape	Town,	South	Africa.	Int	J	Tuberc	Lung	Dis,	14(2),	149-154.		
Munoz,	L.,	Stagg,	H.	R.,	&	Abubakar,	I.	(2015).	Diagnosis	and	Management	of	Latent	
Tuberculosis	Infection.	Cold	Spring	Harb	Perspect	Med,	5(11).	
doi:10.1101/cshperspect.a017830	
Murphy,	K.	(2011).	Janeway's	Immunobiology	(8th	ed.).	
Myllymäki,	H.,	Niskanen,	M.,	Oksanen,	K.	E.,	&	Rämet,	M.	(2015).	Animal	models	in	
tuberculosis	research	–	where	is	the	beef?	doi:1049529	
Ordway,	D.,	Henao-Tamayo,	M.,	Shanley,	C.,	Smith,	E.	E.,	Palanisamy,	G.,	Wang,	B.,	.	.	.	Orme,	I.	
M.	(2008).	Influence	of	Mycobacterium	bovis	BCG	Vaccination	on	Cellular	Immune	
Response	of	Guinea	Pigs	Challenged	with	Mycobacterium	tuberculosis▿.	Clin	Vaccine	
Immunol,	15(8),	1248-1258.	doi:10.1128/cvi.00019-08	
Ordway,	D.	J.,	&	Orme,	I.	M.	(2011).	Animal	models	of	mycobacteria	infection.	Curr	Protoc	
Immunol,	Chapter	19,	Unit19.15.	doi:10.1002/0471142735.im1905s94	
Orme,	I.	M.	(2015).	Tuberculosis	Vaccine	Types	and	Timings.	Clin	Vaccine	Immunol,	22(3),	
249-257.	doi:10.1128/cvi.00718-14	
	 114	
Orme,	I.	M.,	&	Basaraba,	R.	J.	(2014).	The	formation	of	the	granuloma	in	tuberculosis	
infection.	Semin	Immunol,	26(6),	601-609.	doi:10.1016/j.smim.2014.09.009	
Orme,	I.	M.,	Robinson,	R.	T.,	&	Cooper,	A.	M.	(2015).	The	balance	between	protective	and	
pathogenic	immune	responses	in	the	TB-infected	lung.	Nat	Immunol,	16(1),	57-63.	
doi:10.1038/ni.3048	
Overgaard,	N.	H.,	Jung,	J.	W.,	Steptoe,	R.	J.,	&	Wells,	J.	W.	(2015).	CD4+/CD8+	double-positive	
T	cells:	more	than	just	a	developmental	stage?	J	Leukoc	Biol,	97(1),	31-38.	
doi:10.1189/jlb.1RU0814-382	
Padilla-Carlin,	D.	J.,	McMurray,	D.	N.,	&	Hickey,	A.	J.	(2008).	The	Guinea	Pig	as	a	Model	of	
Infectious	Diseases.	Comp	Med,	58(4),	324-340.		
Plopper,	C.	G.,	&	Harkema,	J.	R.	(2005).	The	Respiratory	System	and	its	Use	in	Research	The	
Laboratory	Primate:	Elsevier	Ltd.	
PrabhuDas,	M.,	Adkins,	B.,	Gans,	H.,	King,	C.,	Levy,	O.,	Ramilo,	O.,	&	Siegrist,	C.	A.	(2011).	
Challenges	in	infant	immunity:	implications	for	responses	to	infection	and	vaccines.	
Nat	Immunol,	12(3),	189-194.	doi:10.1038/ni0311-189	
Robinson,	R.	T.,	Orme,	I.	M.,	&	Cooper,	A.	M.	(2015).	The	onset	of	adaptive	immunity	in	the	
mouse	model	of	tuberculosis	and	the	factors	that	compromise	its	expression.	
Immunol	Rev,	264(1),	46-59.	doi:10.1111/imr.12259	
Russell,	D.	G.	(2011).	Mycobacterium	tuberculosis	and	the	intimate	discourse	of	a	chronic	
infection.	Immunol	Rev,	240(1),	252-268.	doi:10.1111/j.1600-065X.2010.00984.x	
Russell,	D.	G.,	Cardona,	P.	J.,	Kim,	M.	J.,	Allain,	S.,	&	Altare,	F.	(2009).	Foamy	macrophages	
and	the	progression	of	the	human	tuberculosis	granuloma.	Nat	Immunol,	10(9),	943-
948.	doi:10.1038/ni.1781	
Saalmuller,	A.,	Reddehase,	M.	J.,	Buhring,	H.	J.,	Jonjic,	S.,	&	Koszinowski,	U.	H.	(1987).	
Simultaneous	expression	of	CD4	and	CD8	antigens	by	a	substantial	proportion	of	
resting	porcine	T	lymphocytes.	Eur	J	Immunol,	17(9),	1297-1301.	
doi:10.1002/eji.1830170912	
Saalmuller,	A.,	Werner,	T.,	&	Fachinger,	V.	(2002).	T-helper	cells	from	naive	to	committed.	
Vet	Immunol	Immunopathol,	87(3-4),	137-145.		
Salmon,	H.,	Berri,	M.,	Gerdts,	V.,	&	Meurens,	F.	(2009).	Humoral	and	cellular	factors	of	
maternal	immunity	in	swine.	Dev	Comp	Immunol,	33(3),	384-393.	
doi:10.1016/j.dci.2008.07.007	
Sanchez-Schmitz,	G.,	&	Levy,	O.	(2011).	Development	of	newborn	and	infant	vaccines.	Sci	
Transl	Med,	3(90),	90ps27.	doi:10.1126/scitranslmed.3001880	
Schnitzlein,	W.	M.,	&	Zuckermann,	F.	A.	(1998).	Determination	of	the	specificity	of	CD45	and	
CD45R	monoclonal	antibodies	through	the	use	of	transfected	hamster	cells	
producing	individual	porcine	CD45	isoforms.	Vet	Immunol	Immunopathol,	60(3-4),	
389-401.		
Seddon,	J.	A.,	&	Shingadia,	D.	(2014).	Epidemiology	and	disease	burden	of	tuberculosis	in	
children:	a	global	perspective.	Infect	Drug	Resist,	7,	153-165.	
doi:10.2147/IDR.S45090	
Sinkora,	J.,	Rehakova,	Z.,	Sinkora,	M.,	Cukrowska,	B.,	&	Tlaskalova-Hogenova,	H.	(2002).	
Early	development	of	immune	system	in	pigs.	Vet	Immunol	Immunopathol,	87(3-4),	
301-306.		
Sinkora,	M.,	&	Butler,	J.	E.	(2009).	The	ontogeny	of	the	porcine	immune	system.	Dev	Comp	
Immunol,	33(3),	273-283.	doi:10.1016/j.dci.2008.07.011	
	 115	
Sinkora,	M.,	&	Butler,	J.	E.	(2016).	Progress	in	the	use	of	swine	in	developmental	
immunology	of	B	and	T	lymphocytes.	Dev	Comp	Immunol,	58,	1-17.	
doi:10.1016/j.dci.2015.12.003	
Sinkora,	M.,	Sinkora,	J.,	Rehakova,	Z.,	Splichal,	I.,	Yang,	H.,	Parkhouse,	R.	M.,	&	Trebichavsk,	I.	
(1998).	Prenatal	ontogeny	of	lymphocyte	subpopulations	in	pigs.	Immunology,	
95(4),	595-603.		
Soares,	A.	P.,	Kwong	Chung,	C.	K.	C.,	Choice,	T.,	Hughes,	E.	J.,	Jacobs,	G.,	van	Rensburg,	E.	J.,	.	.	.	
Hanekom,	W.	A.	(2013).	Longitudinal	Changes	in	CD4+	T-Cell	Memory	Responses	
Induced	by	BCG	Vaccination	of	Newborns.	J	Infect	Dis,	207(7),	1084-1094.	
doi:10.1093/infdis/jis941	
Soares,	A.	P.,	Scriba,	T.	J.,	Joseph,	S.,	Harbacheuski,	R.,	Murray,	R.	A.,	Gelderbloem,	S.	J.,	.	.	.	
Hanekom,	W.	A.	(2008).	Bacillus	Calmette-Guérin	Vaccination	of	Human	Newborns	
Induces	T	Cells	with	Complex	Cytokine	and	Phenotypic	Profiles.	The	Journal	of	
Immunology,	180,	3569-3577.	doi:10.4049/jimmunol.180.5.3569	
Stepanova,	H.,	Samankova,	P.,	Leva,	L.,	Sinkora,	J.,	&	Faldyna,	M.	(2007).	Early	postnatal	
development	of	the	immune	system	in	piglets:	the	redistribution	of	T	lymphocyte	
subsets.	Cell	Immunol,	249(2),	73-79.	doi:10.1016/j.cellimm.2007.11.007	
Summerfield,	A.	(2009).	Special	issue	on	porcine	immunology:	An	introduction	from	the	
guest	editor.	33(3),	265–266.	doi:10.1016/j.dci.2008.07.014	
Sundt,	T.	M.,	3rd,	LeGuern,	C.,	Germana,	S.,	Smith,	C.	V.,	Nakajima,	K.,	Lunney,	J.	K.,	&	Sachs,	
D.	H.	(1992).	Characterization	of	a	polymorphism	of	CD4	in	miniature	swine.	J	
Immunol,	148(10),	3195-3201.		
Talker,	S.	C.,	Kaser,	T.,	Reutner,	K.,	Sedlak,	C.,	Mair,	K.	H.,	Koinig,	H.,	.	.	.	Gerner,	W.	(2013).	
Phenotypic	maturation	of	porcine	NK-	and	T-cell	subsets.	Dev	Comp	Immunol,	40(1),	
51-68.	doi:10.1016/j.dci.2013.01.003	
Tameris,	M.	D.,	Hatherill,	M.,	Landry,	B.	S.,	Scriba,	T.	J.,	Snowden,	M.	A.,	Lockhart,	S.,	.	.	.	Team,	
M.	A.	T.	S.	(2013).	Safety	and	efficacy	of	MVA85A,	a	new	tuberculosis	vaccine,	in	
infants	previously	vaccinated	with	BCG:	a	randomised,	placebo-controlled	phase	2b	
trial.	Lancet,	381(9871),	1021-1028.	doi:10.1016/S0140-6736(13)60177-4	
Tena-Coki,	N.	G.,	Scriba,	T.	J.,	Peteni,	N.,	Eley,	B.,	Wilkinson,	R.	J.,	Andersen,	P.,	.	.	.	
Kampmann,	B.	(2010).	CD4	and	CD8	T-cell	responses	to	mycobacterial	antigens	in	
African	children.	Am	J	Respir	Crit	Care	Med,	182(1),	120-129.	
doi:10.1164/rccm.200912-1862OC	
Thoen,	C.	O.,	Lobue,	P.	A.,	Enarson,	D.	A.,	Kaneene,	J.	B.,	&	de	Kantor,	I.	N.	(2009).	
Tuberculosis:	a	re-emerging	disease	in	animals	and	humans.	Vet	Ital,	45(1),	135-
181.		
UNITAID.	(2016).	TB	XPERT	Project-	Rolling	Out	Innovative	MDR-TB	diagnostics.			
Retrieved	from	http://www.unitaid.eu/en/mdr-tb-diagnostics	
van	Mierlo,	G.	J.,	Frieke	Kuper,	C.,	de	Zeeuw-Brower,	M.-L.,	Schijf,	M.	A.,	Bruijntjes,	J.	P.,	Otto,	
M.,	.	.	.	H,	P.	A.	(2013).	A	Sub	Acute	Immunotoxicity	Study	in	G�ttingen	Mini-pigs�	
with	theImmunosuppressive	Compounds	Cyclosporin	A	and	Dexamethasone.	
Clinical	&	Experimental	Pharmacology,	2013.	doi:10.4172/2161-1459.S4-006	
Vantourout,	P.,	&	Hayday,	A.	(2013).	Six-of-the-best:	unique	contributions	of	gammadelta	T	
cells	to	immunology.	Nat	Rev	Immunol,	13(2),	88-100.	doi:10.1038/nri3384	
	 116	
Verreck,	F.	A.,	Vervenne,	R.	A.,	Kondova,	I.,	van	Kralingen,	K.	W.,	Remarque,	E.	J.,	Braskamp,	
G.,	.	.	.	Thomas,	A.	W.	(2009).	MVA.85A	boosting	of	BCG	and	an	attenuated,	phoP	
deficient	M.	tuberculosis	vaccine	both	show	protective	efficacy	against	tuberculosis	
in	rhesus	macaques.	PLoS	One,	4(4),	e5264.	doi:10.1371/journal.pone.0005264	
Wang,	H.	Y.,	Kim,	H.,	Kim,	S.,	Kim,	D.	K.,	Cho,	S.	N.,	&	Lee,	H.	(2015).	Performance	of	a	real-
time	PCR	assay	for	the	rapid	identification	of	Mycobacterium	species.	J	Microbiol,	
53(1),	38-46.	doi:10.1007/s12275-015-4495-8	
WHO.	(2004).	Weekly	Epidemiological	Record	(0049-8114).	Retrieved	from	
http://www.who.int/wer/2004/en/wer7904.pdf?ua=1	
WHO.	(2009).	WHO	Informal	Consultation	on	Standardization	and	Evaluation	of	BCG	
Vaccines.	Retrieved	from	
http://www.who.int/biologicals/publications/meetings/areas/vaccines/bcg/BCG_
meeting_report_2009v7_FOR_WEB_10JUNE.pdf?ua=1	
WHO.	(2010a).	Multidrug	and	extensively	drug-resistant	TB	(M/XDR-TB):	2010	global	report	
on	surveillance	and	response.	Retrieved	from	
http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdf?ua=
1&ua=1	
WHO.	(2010b,	2010-12-02	03:57:17).	The	five	elements	of	DOTS.	WHO.		Retrieved	from	
http://www.who.int/tb/dots/whatisdots/en/index4.html	
WHO.	(2010c).	Treatment	of	tuberculosis.	Retrieved	from	
http://www.who.int/tb/publications/9789241547833/en/	
WHO.	(2013a).	Annex	3	Recommendations	to	assure	the	quality,	safety	and	e	cacy	of	BCG	
vaccines.	Retrieved	from	
http://www.who.int/biologicals/areas/vaccines/TRS_979_Annex_3.pdf?ua=1	
WHO.	(2013b).	Roadmap	for	Childhood	TB:	Toward	zero	deaths.			Retrieved	from	
http://apps.who.int/iris/bitstream/10665/89506/1/9789241506137_eng.pdf?ua=
1&ua=1	
WHO.	(2014).	Xpert	MTB/RIF	implementation	manual	Technical	and	operational	‘how-to’:	
practical	considerations	(978	92	4	150670	0).	Retrieved	from	
http://apps.who.int/iris/bitstream/10665/112469/1/9789241506700_eng.pdf?ua
=1	
WHO.	(2015a,	2015-10-27	23:22:11).	Childhood	tuberculosis.	WHO.		Retrieved	from	
http://www.who.int/tb/areas-of-work/children/en/	
WHO.	(2015b,	2015-11-25	17:57:37).	Drug-resistant	tuberculosis.	WHO.		Retrieved	from	
http://www.who.int/tb/areas-of-work/drug-resistant-tb/en/	
WHO.	(2015c).	Global	Tuberculosis	Report.	Retrieved	from	
http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua
=1	
WHO.	(2015d).	Guidelines	on	the	management	of	latent	tuberculosis	infection.	Retrieved	
from	http://www.who.int/tb/publications/ltbi_document_page/en/	
WHO.	(2015e).	Implementing	tuberculosis	diagnostics:	A	policy	framework	(978	92	4	
150861	2).	Retrieved	from	
http://apps.who.int/iris/bitstream/10665/162712/1/9789241508612_eng.pdf?ua
=1&ua=1	
WHO.	(2015f,	2015-11-16	14:42:17).	Tuberculosis	(TB).	WHO.		Retrieved	from	
http://www.who.int/topics/tuberculosis/en/	
	 117	
WHO.	(2016).	Guidance	for	national	tuberculosis	programmes	on	the	management	of	
tuberculosis	in	children.	Retrieved	from	
http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf?ua
=1	
Williams,	A.,	Hall,	Y.,	&	Orme,	I.	M.	(2009).	Evaluation	of	new	vaccines	for	tuberculosis	in	
the	guinea	pig	model.	Tuberculosis	(Edinb),	89(6),	389-397.	
doi:10.1016/j.tube.2009.08.004	
Zaghouani,	H.,	Hoeman,	C.	M.,	&	Adkins,	B.	(2009).	Neonatal	immunity:	faulty	T-helpers	and	
the	shortcomings	of	dendritic	cells.	Trends	Immunol,	30(12),	585-591.	
doi:10.1016/j.it.2009.09.002	
	
	
	
		
	
	
